Recent News

• 04.17.2025 - Nanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC X
• 03.31.2025 - Fourth Quarter 2024 Financial and Operating Results
• 03.31.2025 - Nanox Announces Fourth Quarter of 2024 Financial Results and Provides Business Updates
• 03.26.2025 - Nanox to Present New Data Featuring AI Bone Solution at Four Medical Conferences through June 2025 across Europe
• 03.17.2025 - Nanox to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025
• 02.25.2025 - Nanox to Present New Clinical Data on Nanox.ARC Advanced 3D Digital Tomosynthesis Imaging System at ECR 2025
• 02.25.2025 - Nanox.ARC Imaging System Receives CE Mark, Expanding Medical Imaging Offering in European Market
• 02.17.2025 - Atlantic Health System: Leveraging AI for Opportunistic Screening: Identifying Coronary Artery Calcification on Non-ECG Gated Lung Cancer Screening Chest CT
• 02.10.2025 - How AI can spot diseases that doctors aren’t looking for
• 02.10.2025 - Using Artificial Intelligence to Semi-Quantitate Coronary Calcium as an ‘Incidentaloma’ on Non-Gated, Non-Contrast CT Scans, A Single-Center Descriptive Study in West Michigan.

Recent Filings

• 04.17.2025 - EX-99.1 EX-99.1
• 04.17.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.09.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 03.31.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.31.2025 - EX-99.1 EX-99.1
• 02.25.2025 - EX-99.1 EX-99.1
• 02.25.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.13.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]